Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 167

1.

Evaluation of tourism impact on soil metal accumulation through single and integrated indices.

Memoli V, Esposito F, Panico SC, De Marco A, Barile R, Maisto G.

Sci Total Environ. 2019 Sep 10;682:685-691. doi: 10.1016/j.scitotenv.2019.05.211. Epub 2019 May 17.

PMID:
31129550
2.

Quercus ilex L. leaves as filters of air Cd, Cr, Cu, Ni and Pb.

Esposito F, Memoli V, Di Natale G, Trifuoggi M, Maisto G.

Chemosphere. 2019 Mar;218:340-346. doi: 10.1016/j.chemosphere.2018.11.133. Epub 2018 Nov 21.

PMID:
30476765
3.

Overall plant responses to Cd and Pb metal stress in maize: Growth pattern, ultrastructure, and photosynthetic activity.

Figlioli F, Sorrentino MC, Memoli V, Arena C, Maisto G, Giordano S, Capozzi F, Spagnuolo V.

Environ Sci Pollut Res Int. 2019 Jan;26(2):1781-1790. doi: 10.1007/s11356-018-3743-y. Epub 2018 Nov 19.

PMID:
30456613
4.

Soil element fractions affect phytotoxicity, microbial biomass and activity in volcanic areas.

Memoli V, Eymar E, García-Delgado C, Esposito F, Panico SC, De Marco A, Barile R, Maisto G.

Sci Total Environ. 2018 Sep 15;636:1099-1108. doi: 10.1016/j.scitotenv.2018.04.327. Epub 2018 May 3.

PMID:
29913572
5.

Central xanthoma of the jaw in association with Noonan syndrome.

Olson NJ, Addante RR, de Abreu FB, Memoli VA.

Hum Pathol. 2018 Dec;82:202-205. doi: 10.1016/j.humpath.2018.04.020. Epub 2018 May 1.

PMID:
29727697
6.

Total and fraction content of elements in volcanic soil: Natural or anthropogenic derivation.

Memoli V, Eymar E, García-Delgado C, Esposito F, Santorufo L, De Marco A, Barile R, Maisto G.

Sci Total Environ. 2018 Jun 1;625:16-26. doi: 10.1016/j.scitotenv.2017.12.223. Epub 2017 Dec 26.

PMID:
29287209
7.

Deubiquitinase USP18 Loss Mislocalizes and Destabilizes KRAS in Lung Cancer.

Mustachio LM, Lu Y, Tafe LJ, Memoli V, Rodriguez-Canales J, Mino B, Villalobos PA, Wistuba I, Katayama H, Hanash SM, Roszik J, Kawakami M, Cho KJ, Hancock JF, Chinyengetere F, Hu S, Liu X, Freemantle SJ, Dmitrovsky E.

Mol Cancer Res. 2017 Jul;15(7):905-914. doi: 10.1158/1541-7786.MCR-16-0369. Epub 2017 Feb 27.

8.

A case of CIC-rearranged undifferentiated round-cell sarcoma with exclusive spindled morphology and diffuse CD99 positivity: a potential pitfall.

Hery AL, Ornvold K, Memoli V, Bridge J, Linos K.

Histopathology. 2017 Jan;70(2):314-316. doi: 10.1111/his.13051. Epub 2016 Oct 24. No abstract available.

PMID:
27482634
9.

Clinical Genotyping of Non-Small Cell Lung Cancers Using Targeted Next-Generation Sequencing: Utility of Identifying Rare and Co-mutations in Oncogenic Driver Genes.

Tafe LJ, Pierce KJ, Peterson JD, de Abreu F, Memoli VA, Black CC, Pettus JR, Marotti JD, Gutmann EJ, Liu X, Shirai K, Dragnev KH, Amos CI, Tsongalis GJ.

Neoplasia. 2016 Sep;18(9):577-83. doi: 10.1016/j.neo.2016.07.010.

10.

Mice null for the deubiquitinase USP18 spontaneously develop leiomyosarcomas.

Chinyengetere F, Sekula DJ, Lu Y, Giustini AJ, Sanglikar A, Kawakami M, Ma T, Burkett SS, Eisenberg BL, Wells WA, Hoopes PJ, Demicco EG, Lazar AJ, Torres KE, Memoli V, Freemantle SJ, Dmitrovsky E.

BMC Cancer. 2015 Nov 10;15:886. doi: 10.1186/s12885-015-1883-8.

11.

Effective capture of circulating tumor cells from a transgenic mouse lung cancer model using dendrimer surfaces immobilized with anti-EGFR.

Myung JH, Roengvoraphoj M, Tam KA, Ma T, Memoli VA, Dmitrovsky E, Freemantle SJ, Hong S.

Anal Chem. 2015 Oct 6;87(19):10096-102. doi: 10.1021/acs.analchem.5b02766. Epub 2015 Sep 10.

12.

Implementation of a Molecular Tumor Board: The Impact on Treatment Decisions for 35 Patients Evaluated at Dartmouth-Hitchcock Medical Center.

Tafe LJ, Gorlov IP, de Abreu FB, Lefferts JA, Liu X, Pettus JR, Marotti JD, Bloch KJ, Memoli VA, Suriawinata AA, Dragnev KH, Fadul CE, Schwartz GN, Morgan CR, Holderness BM, Peterson JD, Tsongalis GJ, Miller TW, Chamberlin MD.

Oncologist. 2015 Sep;20(9):1011-8. doi: 10.1634/theoncologist.2015-0097. Epub 2015 Jul 23.

13.
14.

Cell cycle and apoptosis regulatory proteins, proliferative markers, cell signaling molecules, CD209, and decorin immunoreactivity in low-grade myxofibrosarcoma and myxoma.

Cates JM, Memoli VA, Gonzalez RS.

Virchows Arch. 2015 Aug;467(2):211-6. doi: 10.1007/s00428-015-1778-8. Epub 2015 May 5.

PMID:
25940995
15.

CDK2 Inhibition Causes Anaphase Catastrophe in Lung Cancer through the Centrosomal Protein CP110.

Hu S, Danilov AV, Godek K, Orr B, Tafe LJ, Rodriguez-Canales J, Behrens C, Mino B, Moran CA, Memoli VA, Mustachio LM, Galimberti F, Ravi S, DeCastro A, Lu Y, Sekula D, Andrew AS, Wistuba II, Freemantle S, Compton DA, Dmitrovsky E.

Cancer Res. 2015 May 15;75(10):2029-38. doi: 10.1158/0008-5472.CAN-14-1494. Epub 2015 Mar 25.

16.

Failure of Primary Total Hip Arthroplasty Secondary to New Onset of Paget Disease: A Case Report.

Amundsen S, Koenig K, Goodwin D, Memoli V.

JBJS Case Connect. 2015 Mar 11;5(1):e19-e5. doi: 10.2106/JBJS.CC.M.00096.

PMID:
29252573
17.

Small cell neuroendocrine carcinomas of the lung do not harbor high-risk human papillomavirus.

Hartley CP, Steinmetz HB, Memoli VA, Tafe LJ.

Hum Pathol. 2015 Apr;46(4):577-82. doi: 10.1016/j.humpath.2014.12.012. Epub 2015 Jan 9.

PMID:
25661244
18.

Breast MRI-detected cystic apocrine metaplasia: imaging features with microvessel analysis and histologic correlation.

diFlorio-Alexander RM, Marotti JD, Bond JS, Schwab MC, Memoli VA, Wells WA, Poplack SP.

AJR Am J Roentgenol. 2015 Jan;204(1):211-8. doi: 10.2214/AJR.14.12869.

PMID:
25539259
19.

Social confidence in unions: a U.S.-Canada comparison.

Frangi L, Hennebert MA, Memoli V.

Can Rev Sociol. 2014 May;51(2):170-88.

PMID:
24964521
20.

ALK-rearranged adenosquamous lung cancer presenting as squamous cell carcinoma: a potential challenge to histologic type triaging of NSCLC biopsies for molecular studies.

Dragnev KH, Gehr G, Memoli VA, Tafe LJ.

Clin Lung Cancer. 2014 May;15(3):e37-40. doi: 10.1016/j.cllc.2014.01.003. Epub 2014 Jan 18. No abstract available.

PMID:
24524823
21.

All-trans-retinoic acid antagonizes the Hedgehog pathway by inducing patched.

Busch AM, Galimberti F, Nehls KE, Roengvoraphoj M, Sekula D, Li B, Guo Y, Direnzo J, Fiering SN, Spinella MJ, Robbins DJ, Memoli VA, Freemantle SJ, Dmitrovsky E.

Cancer Biol Ther. 2014 Apr;15(4):463-72. doi: 10.4161/cbt.27821. Epub 2014 Feb 4.

22.

Comparing histone deacetylase inhibitor responses in genetically engineered mouse lung cancer models and a window of opportunity trial in patients with lung cancer.

Ma T, Galimberti F, Erkmen CP, Memoli V, Chinyengetere F, Sempere L, Beumer JH, Anyang BN, Nugent W, Johnstone D, Tsongalis GJ, Kurie JM, Li H, Direnzo J, Guo Y, Freemantle SJ, Dragnev KH, Dmitrovsky E.

Mol Cancer Ther. 2013 Aug;12(8):1545-55. doi: 10.1158/1535-7163.MCT-12-0933. Epub 2013 May 16.

23.

Adenoid cystic carcinoma of the breast in reduction mammoplasty.

Xue Y, Liu X, Poplack S, Memoli VA.

Breast J. 2012 Nov-Dec;18(6):611-3. doi: 10.1111/tbj.12029. Epub 2012 Oct 19. No abstract available.

PMID:
23078292
24.

Response to inhibition of smoothened in diverse epithelial cancer cells that lack smoothened or patched 1 mutations.

Galimberti F, Busch AM, Chinyengetere F, Ma T, Sekula D, Memoli VA, Dragnev KH, Liu F, Johnson KC, Guo Y, Freemantle SJ, Andrew AS, Greninger P, Robbins DJ, Settleman J, Benes C, Dmitrovsky E.

Int J Oncol. 2012 Nov;41(5):1751-61. doi: 10.3892/ijo.2012.1599. Epub 2012 Aug 22.

25.

Evidence for the ubiquitin protease UBP43 as an antineoplastic target.

Guo Y, Chinyengetere F, Dolinko AV, Lopez-Aguiar A, Lu Y, Galimberti F, Ma T, Feng Q, Sekula D, Freemantle SJ, Andrew AS, Memoli V, Dmitrovsky E.

Mol Cancer Ther. 2012 Sep;11(9):1968-77. doi: 10.1158/1535-7163.MCT-12-0248. Epub 2012 Jul 2.

26.

Pseudoangiomatous stromal hyperplasia of the breast in a 10-year-old girl.

Baker M, Chen H, Latchaw L, Memoli V, Ornvold K.

J Pediatr Surg. 2011 Aug;46(8):e27-31. doi: 10.1016/j.jpedsurg.2011.04.063.

PMID:
21843705
27.

Cytomorphologic features of advanced lung adenocarcinomas tested for EGFR and KRAS mutations: a retrospective review of 50 cases.

Marotti JD, Schwab MC, McNulty NJ, Rigas JR, DeLong PA, Memoli VA, Tsongalis GJ, Padmanabhan V.

Diagn Cytopathol. 2013 Jan;41(1):15-21. doi: 10.1002/dc.21749. Epub 2011 Jun 16.

PMID:
21681971
28.

Orthopaedic specimen preparation: what pathologists should know and do.

Klein MJ, Memoli VA.

Semin Diagn Pathol. 2011 Feb;28(1):4-12. Review.

PMID:
21675373
29.

Bexarotene plus erlotinib suppress lung carcinogenesis independent of KRAS mutations in two clinical trials and transgenic models.

Dragnev KH, Ma T, Cyrus J, Galimberti F, Memoli V, Busch AM, Tsongalis GJ, Seltzer M, Johnstone D, Erkmen CP, Nugent W, Rigas JR, Liu X, Freemantle SJ, Kurie JM, Waxman S, Dmitrovsky E.

Cancer Prev Res (Phila). 2011 Jun;4(6):818-28. doi: 10.1158/1940-6207.CAPR-10-0376.

30.

High cyclin D3 expression confers erlotinib resistance in aerodigestive tract cancer.

Petty WJ, Voelzke WR, Urbanic JJ, Varela VA, Waller LL, Swift CB, Graham RM, Memoli VA, Dragnev KH.

Lung Cancer. 2011 Dec;74(3):384-91. doi: 10.1016/j.lungcan.2011.04.004. Epub 2011 May 8.

PMID:
21555162
31.

Mucolipidosis type III α/β: the first characterization of this rare disease by autopsy.

Kerr DA, Memoli VA, Cathey SS, Harris BT.

Arch Pathol Lab Med. 2011 Apr;135(4):503-10. doi: 10.1043/2010-0236-CR.1.

32.

Lipoprotein lipase links dietary fat to solid tumor cell proliferation.

Kuemmerle NB, Rysman E, Lombardo PS, Flanagan AJ, Lipe BC, Wells WA, Pettus JR, Froehlich HM, Memoli VA, Morganelli PM, Swinnen JV, Timmerman LA, Chaychi L, Fricano CJ, Eisenberg BL, Coleman WB, Kinlaw WB.

Mol Cancer Ther. 2011 Mar;10(3):427-36. doi: 10.1158/1535-7163.MCT-10-0802. Epub 2011 Jan 31.

33.
34.

Native MAG-1 antibody almost destroys human breast cancer xenografts.

North WG, Pang RH, Gao G, Memoli VA, Cole BF.

Breast Cancer Res Treat. 2011 Jun;127(3):631-7. doi: 10.1007/s10549-010-1009-6. Epub 2010 Jul 13.

35.

Unusual manifestation of parathyroid carcinoma in the setting of papillary thyroid cancer.

Chaychi L, Belbruno K, Golding A, Memoli V.

Endocr Pract. 2010 Jul-Aug;16(4):664-8. doi: 10.4158/EP10061.CR. Review.

PMID:
20439239
36.

MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors.

Liu X, Sempere LF, Ouyang H, Memoli VA, Andrew AS, Luo Y, Demidenko E, Korc M, Shi W, Preis M, Dragnev KH, Li H, Direnzo J, Bak M, Freemantle SJ, Kauppinen S, Dmitrovsky E.

J Clin Invest. 2010 Apr;120(4):1298-309. doi: 10.1172/JCI39566. Epub 2010 Mar 8.

37.

Unusual recurrence of hypercalcemia due to concurrent parathyroid adenoma and parathyroid sarcoidosis with lymph node involvement.

Chaychi L, Chaidarun S, Golding A, Kinlaw WB, Memoli V, Siegel A.

Endocr Pract. 2010 May-Jun;16(3):463-7. doi: 10.4158/EP09325.CR.

PMID:
20061287
38.

NMDA receptors are expressed by small-cell lung cancer and are potential targets for effective treatment.

North WG, Gao G, Jensen A, Memoli VA, Du J.

Clin Pharmacol. 2010;2:31-40. doi: 10.2147/CPAA.S6262. Epub 2010 Apr 1.

39.

Targeting the cyclin E-Cdk-2 complex represses lung cancer growth by triggering anaphase catastrophe.

Galimberti F, Thompson SL, Liu X, Li H, Memoli V, Green SR, DiRenzo J, Greninger P, Sharma SV, Settleman J, Compton DA, Dmitrovsky E.

Clin Cancer Res. 2010 Jan 1;16(1):109-20. doi: 10.1158/1078-0432.CCR-09-2151. Epub 2009 Dec 22.

40.

Breast cancer expresses functional NMDA receptors.

North WG, Gao G, Memoli VA, Pang RH, Lynch L.

Breast Cancer Res Treat. 2010 Jul;122(2):307-14. doi: 10.1007/s10549-009-0556-1. Epub 2009 Sep 26.

41.

Uncovering growth-suppressive MicroRNAs in lung cancer.

Liu X, Sempere LF, Galimberti F, Freemantle SJ, Black C, Dragnev KH, Ma Y, Fiering S, Memoli V, Li H, DiRenzo J, Korc M, Cole CN, Bak M, Kauppinen S, Dmitrovsky E.

Clin Cancer Res. 2009 Feb 15;15(4):1177-83. doi: 10.1158/1078-0432.CCR-08-1355.

42.

Arsenic activates EGFR pathway signaling in the lung.

Andrew AS, Mason RA, Memoli V, Duell EJ.

Toxicol Sci. 2009 Jun;109(2):350-7. doi: 10.1093/toxsci/kfp015. Epub 2009 Jan 23.

43.

UBE1L causes lung cancer growth suppression by targeting cyclin D1.

Feng Q, Sekula D, Guo Y, Liu X, Black CC, Galimberti F, Shah SJ, Sempere LF, Memoli V, Andersen JB, Hassel BA, Dragnev K, Dmitrovsky E.

Mol Cancer Ther. 2008 Dec;7(12):3780-8. doi: 10.1158/1535-7163.MCT-08-0753.

44.

Testicular maturation arrest to testis cancer: spectrum of expression of the vitamin D receptor and vitamin D treatment in vitro.

Nangia AK, Hill O, Waterman MD, Schwender CE, Memoli V.

J Urol. 2007 Sep;178(3 Pt 1):1092-6. Epub 2007 Jul 20.

PMID:
17644135
45.

A proof-of-principle clinical trial of bexarotene in patients with non-small cell lung cancer.

Dragnev KH, Petty WJ, Shah SJ, Lewis LD, Black CC, Memoli V, Nugent WC, Hermann T, Negro-Vilar A, Rigas JR, Dmitrovsky E.

Clin Cancer Res. 2007 Mar 15;13(6):1794-800.

46.

Transgenic cyclin E triggers dysplasia and multiple pulmonary adenocarcinomas.

Ma Y, Fiering S, Black C, Liu X, Yuan Z, Memoli VA, Robbins DJ, Bentley HA, Tsongalis GJ, Demidenko E, Freemantle SJ, Dmitrovsky E.

Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):4089-94. Epub 2007 Feb 27.

47.

Uncovering novel targets for cancer chemoprevention.

Dragnev KH, Feng Q, Ma Y, Shah SJ, Black C, Memoli V, Nugent W, Rigas JR, Kitareewan S, Freemantle S, Dmitrovsky E.

Recent Results Cancer Res. 2007;174:235-43. Review.

PMID:
17302201
48.

Repression of cyclin D1 as a target for germ cell tumors.

Freemantle SJ, Vaseva AV, Ewings KE, Bee T, Krizan KA, Kelley MR, Hattab EM, Memoli VA, Black CC, Spinella MJ, Dmitrovsky E.

Int J Oncol. 2007 Feb;30(2):333-40.

PMID:
17203214
49.

Frequent requirement of hedgehog signaling in non-small cell lung carcinoma.

Yuan Z, Goetz JA, Singh S, Ogden SK, Petty WJ, Black CC, Memoli VA, Dmitrovsky E, Robbins DJ.

Oncogene. 2007 Feb 15;26(7):1046-55. Epub 2006 Aug 14.

PMID:
16909105
50.

Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma.

Kinlaw WB, Scott SM, Maue RA, Memoli VA, Harris RD, Daniels GH, Porter DM, Belloni DR, Spooner ET, Ernesti MM, Noll WW.

Clin Endocrinol (Oxf). 2005 Dec;63(6):676-82.

PMID:
16343103

Supplemental Content

Loading ...
Support Center